受强制性开放获取政策约束的文章 - Umar Farooq了解详情
可在其他位置公开访问的文章：53 篇
Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma
SS Neelapu, FL Locke, NL Bartlett, LJ Lekakis, DB Miklos, CA Jacobson, ...
New England Journal of Medicine 377 (26), 2531-2544, 2017
强制性开放获取政策： US National Institutes of Health
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
FL Locke, A Ghobadi, CA Jacobson, DB Miklos, LJ Lekakis, OO Oluwole, ...
The lancet oncology 20 (1), 31-42, 2019
强制性开放获取政策： US National Institutes of Health
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
M Crump, SS Neelapu, U Farooq, E Van Den Neste, J Kuruvilla, J Westin, ...
Blood, The Journal of the American Society of Hematology 130 (16), 1800-1808, 2017
强制性开放获取政策： US National Institutes of Health
Survival with axicabtagene ciloleucel in large B-cell lymphoma
JR Westin, OO Oluwole, MJ Kersten, DB Miklos, MA Perales, A Ghobadi, ...
New England Journal of Medicine 389 (2), 148-157, 2023
强制性开放获取政策： US National Institutes of Health
Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma
SS Neelapu, CA Jacobson, A Ghobadi, DB Miklos, LJ Lekakis, ...
Blood, The Journal of the American Society of Hematology 141 (19), 2307-2315, 2023
强制性开放获取政策： US National Institutes of Health
Autologous transplantation in follicular lymphoma with early therapy failure: a National LymphoCare Study and Center for International Blood and Marrow Transplant Research analysis
C Casulo, JW Friedberg, KW Ahn, C Flowers, A DiGilio, SM Smith, ...
Biology of Blood and Marrow Transplantation 24 (6), 1163-1171, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation
TS Fenske, KW Ahn, TM Graff, A DiGilio, Q Bashir, RT Kamble, E Ayala, ...
British journal of haematology 174 (2), 235-248, 2016
强制性开放获取政策： US National Institutes of Health
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
TC El-Galaly, CY Cheah, MD Bendtsen, GS Nowakowski, R Kansara, ...
European Journal of Cancer 93, 57-68, 2018
强制性开放获取政策： US National Institutes of Health
Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials
MJ Maurer, H Ghesquières, BK Link, JP Jais, TM Habermann, ...
Journal of Clinical Oncology 36 (16), 1603-1610, 2018
强制性开放获取政策： US National Institutes of Health
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ...
Blood, The Journal of the American Society of Hematology 137 (3), 374-386, 2021
强制性开放获取政策： US National Institutes of Health
Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management
AR Murali, S Chandra, Z Stewart, BR Blazar, U Farooq, MN Ince, ...
Transplantation 100 (12), 2661-2670, 2016
强制性开放获取政策： US National Institutes of Health
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
SM Smith, J Godfrey, KW Ahn, A DiGilio, S Ahmed, V Agrawal, ...
Cancer 124 (12), 2541-2551, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Cohort profile: the lymphoma specialized program of research excellence (SPORE) molecular epidemiology resource (MER) Cohort Study
JR Cerhan, BK Link, TM Habermann, MJ Maurer, AL Feldman, SI Syrbu, ...
International journal of epidemiology 46 (6), 1753-1754i, 2017
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs …
Burkitt lymphoma international prognostic index
AJ Olszewski, LH Jakobsen, GP Collins, K Cwynarski, V Bachanova, ...
Journal of clinical oncology 39 (10), 1129-1138, 2021
强制性开放获取政策： US National Institutes of Health
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front‐line immunochemotherapy
U Farooq, MJ Maurer, CA Thompson, G Thanarajasingam, DJ Inwards, ...
British journal of haematology 179 (1), 50-60, 2017
强制性开放获取政策： US National Institutes of Health
Late relapses in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Y Wang, U Farooq, BK Link, MC Larson, RL King, MJ Maurer, C Allmer, ...
Journal of Clinical Oncology 37 (21), 1819-1827, 2019
强制性开放获取政策： US National Institutes of Health
Lower graft-versus-host disease and relapse risk in post-transplant cyclophosphamide–based haploidentical versus matched sibling donor reduced-intensity conditioning transplant …
S Ahmed, JA Kanakry, KW Ahn, C Litovich, H Abdel-Azim, M Aljurf, ...
Biology of blood and marrow transplantation 25 (9), 1859-1868, 2019
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Patient-Centered …
Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant
M Scordo, TP Wang, KW Ahn, Y Chen, S Ahmed, FT Awan, A Beitinjaneh, ...
JAMA oncology 7 (7), 993-1003, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
JP Alderuccio, AJ Olszewski, AM Evens, GP Collins, AV Danilov, M Bower, ...
Blood advances 5 (14), 2852-2862, 2021
强制性开放获取政策： US National Institutes of Health
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma …
N Epperla, KW Ahn, C Litovich, S Ahmed, M Battiwalla, JB Cohen, P Dahi, ...
Journal of Hematology & Oncology 12, 1-11, 2019
强制性开放获取政策： US Department of Defense, US National Institutes of Health
出版信息和资助信息由计算机程序自动确定